Jørgen Hilden

Jørgen Hilden

Associate professor emeritus, Associate Professor emeritus

Member of:


    1. 2011
    2. Published

      Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?

      Winkel, P., Hilden, Jørgen, Hansen, J. F., Hildebrandt, P., Kastrup, J., Kolmos, H. J., Kjøller, E., Jespersen, C. M., Gluud, C., Jensen, G. & CLARICOR Trial, G., 2011, In: Cardiology. 118, 1, p. 63-67

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

      Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: A prognostic study within the CLARICOR Trial

      Iversen, Kasper, Teisner, B., Winkel, P., Gluud, C., Kjøller, E., Kolmos, H. J., Hildebrandt, P. R., Hilden, Jørgen, Kastrup, J. & The CLARICOR Trial Group, T. C. T. G., 1 Jan 2011, In: Atherosclerosis. 214, 1, p. 203-208 6 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial

      Harutyunyan, M. J., Mathiasen, A. B., Winkel, P., Goetze, Jens P. , Hansen, J. F., Hildebrandt, P., Jensen, G. B., Hilden, Jørgen, Jespersen, C. M., Kjøller, E., Kolmos, H. J., Gluud, C., Kastrup, J. & CLARICOR Trial Group, C. T. G., 1 Feb 2011, In: Scandinavian Journal of Clinical & Laboratory Investigation. 71, 1, p. 52-62 11 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    5. 2012
    6. Published

      Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease

      Kjoller, E., Hilden, Jørgen, Winkel, P., Frandsen, N. J., Galatius, S., Jensen, G., Kastrup, J., Hansen, J. F., Kolmos, H. J. J., Jespersen, C. M., Hildebrandt, P., Gluud, C. N. & CLARICOR Trial Group, C. T. G., 2012, In: Journal of Clinical Epidemiology. 65, 4, p. 444-53 10 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    7. Published

      Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

      Hróbjartsson, A., Thomsen, A. S. S., Emanuelsson, F., Tendal, B., Hilden, Jørgen, Boutron, I., Ravaud, P. & Brorson, Stig, 27 Feb 2012, In: B M J (Online). 344, p. e1119

      Research output: Contribution to journalJournal articleResearchpeer-review

    8. Published

      Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

      Hróbjartsson, A., Thomsen, A. S. S., Emanuelsson, F., Tendal, B., Hilden, Jørgen, Boutron, I., Ravaud, P. & Brorson, S., 27 Feb 2012, In: B M J (Clinical Research Edition). 344, 1 p., e1119.

      Research output: Contribution to journalJournal articleResearchpeer-review

    9. 2013
    10. Published

      Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors

      Hróbjartsson, A., Thomsen, A. S. S., Emanuelsson, F., Tendal, B., Hilden, Jørgen, Boutron, I., Ravaud, P. & Brorson, Stig, 5 Mar 2013, In: C M A J. 185, 4, p. E201-11

      Research output: Contribution to journalJournal articleResearchpeer-review

    11. Published

      Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial

      Harutyunyan, M., Goetze, Jens P. , Winkel, P., Johansen, Julia Sidenius, Hansen, J. F., Jensen, G. B., Hilden, Jørgen, Kjøller, E., Kolmos, H. J., Gluud, C. & Kastrup, J., Jul 2013, In: Immunobiology. 218, 7, p. 945-51 7 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    12. 2014
    13. Published

      Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide

      Lyngbæk, S., Winkel, P., Gøtze, J. P., Kastrup, J., Gluud, C., Kolmos, H. J., Kjøller, E., Jensen, G. B., Hansen, J. F., Hildebrandt, P., Hilden, Jørgen & CLARICOR Trial Group, C. T. G., 2014, In: European Journal of Preventive Cardiology. 21, 10, p. 1275-1284 10 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    14. Published

      On NRI, IDI, and "good-looking" statistics with nothing underneath

      Hilden, Jørgen, Mar 2014, In: Epidemiology (Cambridge, Mass.). 25, 2, p. 265-7 3 p.

      Research output: Contribution to journalComment/debateResearchpeer-review

    Previous 1...3 4 5 6 7 8 9 10 Next

    ID: 314941